Jan 15, 2019 by Brian FeroldiWhy Tyme Technologies Is SkyrocketingShares rose sharply after management released upbeat clinical data and scheduled a conference call.
Jan 15, 2019 by Brian Feroldi3 Low-Risk Tech Stocks for a DownturnThe market is making some investors nervous, but you don’t have to give up tech altogether to make your portfolio safer.
Jan 12, 2019 by Brian FeroldiThe Only High-Yield Stocks I'd Consider Buying in 2019These three dividend beasts stand apart from the crowd.
Jan 12, 2019 by Brian FeroldiForget eBay: MercadoLibre Is a Better Growth StockThe Latin American e-commerce giant is going places.
Jan 11, 2019 by Brian FeroldiWhy Aratana Therapeutics Is Tumbling TodayShares fall hard in response to an analyst downgrade. Here's what investors need to know.
Jan 10, 2019 by Brian FeroldiWhy TherapeuticsMD's Stock Spiked TodayTraders are feeling giddy after management shared the bull case for owning its stock at an important investor conference.
Jan 10, 2019 by Brian FeroldiWhy Appian Slumped 15% in 2018Declining revenue growth rates might not have pleased traders, but it wasn't a bad year for the business.
Jan 9, 2019 by Brian FeroldiHere's Why DexCom Skyrocketed 109% in 2018It was a banner year for the medical device maker.
Jan 9, 2019 by Brian FeroldiWhy Globus Medical Is Soaring TodayTraders cheer after the company reports pleasing preliminary results for the fourth quarter and shares bullish guidance.
Jan 7, 2019 by Brian FeroldiWhy Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits TodayShares of all three cancer-focused companies shot higher after one of their peers got bought out for a sizable premium.
Jan 7, 2019 by Brian FeroldiWhy TransEnterix Is Soaring TodayShares jumped after the company provided investors with a slew of positive updates. Here are the key takeaways for investors.
Jan 7, 2019 by Brian FeroldiHere's Why Loxo Oncology Is Skyrocketing TodayShares jumped more than 66% in response to news that the company is being acquired. Here's what investors need to know.
Jan 6, 2019 by Brian FeroldiHere's My Top Stock to Buy for 2019 and BeyondThis business truly has it all.
Jan 4, 2019 by Brian FeroldiThese Dividends Could DoubleLooking for income stocks that promise dividend growth? Check out these three.
Jan 3, 2019 by Brian FeroldiHere's Why BeiGene Is Taking a Hit TodayShares tumble in response to an industry megamerger.
Jan 2, 2019 by Brian FeroldiHere's Why Tandem Diabetes Care Is Dropping TodayShares tumble on a slow news day. What can explain the double-digit move?
Jan 2, 2019 by Brian FeroldiWhy MedEquities Realty Trust Is SkyrocketingShares jump in response to a buyout offer.
Dec 28, 2018 by Brian Feroldi, Sean Williams, and Keith Speights3 Top Small-Cap Stocks to Buy Right NowThese scrawny stocks are bargains that should have investors licking their lips.
Dec 24, 2018 by Brian FeroldiWhy Mindbody Is SkyrocketingShares soar after the company announces that it's being taken private. Did Christmas come a day early for shareholders?
Dec 24, 2018 by Brian FeroldiIs NovoCure a Buy?Investors in the cancer-focused medical device company have enjoyed strong returns already. Is it too late to hop on board?
